Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001209191-22-023695

VP, Research sold 5,000 shares at $25.59 ($127,950)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fairman Jeff VP, Research 2022-04-05 Sale −5,000 $25.59 $127,950 326,227 I: show line 1 in the form
Open-market sales · 5,000 sh · avg $25.59 · $127,950
Loading xslF345X03/doc4.xml…